MENU
+Compare
SCYX
Stock ticker: NASDAQ
AS OF
Jun 12 closing price
Price
$0.82
Change
-$0.06 (-6.82%)
Capitalization
55.88M

SCYX SCYNEXIS Forecast, Technical & Fundamental Analysis

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SCYX with price predictions
Jun 11, 2025

SCYX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for SCYX turned positive on May 30, 2025. Looking at past instances where SCYX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SCYX's RSI Oscillator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where SCYX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCYX advanced for three days, in of 230 cases, the price rose further within the following month. The odds of a continued upward trend are .

SCYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SCYX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SCYX moved below its 50-day moving average on June 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SCYX crossed bearishly below the 50-day moving average on May 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCYX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SCYX entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.766) is normal, around the industry mean (62.115). P/E Ratio (1.065) is within average values for comparable stocks, (88.968). SCYX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (0.511) is also within normal values, averaging (19.096).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SCYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SCYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SCYX is expected to report earnings to rise 78.82% to -19 cents per share on August 18

SCYNEXIS SCYX Stock Earnings Reports
Q2'25
Est.
$-0.20
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.08
Q2'24
Missed
by $0.15
The last earnings report on May 15 showed earnings per share of -10 cents, beating the estimate of -20 cents. With 140.91K shares outstanding, the current market capitalization sits at 55.88M.
A.I. Advisor
published General Information

General Information

a company which engages in discovery, development and commercialization of novel anti infectives

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1 Evertrust Plaza
Phone
+1 201 884-5485
Employees
36
Web
https://www.scynexis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HG21.390.48
+2.30%
Hamilton Insurance Group Ltd
GS625.110.94
+0.15%
Goldman Sachs Group
PNFP105.52-0.85
-0.80%
Pinnacle Financial Partners
UIS4.86-0.10
-2.02%
Unisys Corp
ICCM0.99-0.04
-3.88%
IceCure Medical Ltd

SCYX and Stocks

Correlation & Price change

A.I.dvisor tells us that SCYX and CRDL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
+0.29%
CRDL - SCYX
30%
Poorly correlated
-3.45%
AQST - SCYX
29%
Poorly correlated
-4.75%
ACB - SCYX
29%
Poorly correlated
+1.51%
AKAN - SCYX
28%
Poorly correlated
-4.23%
OGI - SCYX
26%
Poorly correlated
+2.80%
More